HC Wainwright Forecasts Weaker Earnings for Alpha Cognition

Alpha Cognition Inc. (NASDAQ:ACOG) – Investment analysts at HC Wainwright reduced their Q1 2026 EPS estimates for Alpha Cognition in a research report issued to clients and investors on Wednesday, April 8th. HC Wainwright analyst R. Selvaraju now forecasts that the company will earn ($0.28) per share for the quarter, down from their previous forecast of ($0.24). HC Wainwright currently has a “Buy” rating and a $18.00 price objective on the stock. HC Wainwright also issued estimates for Alpha Cognition’s Q3 2026 earnings at ($0.29) EPS, Q4 2026 earnings at ($0.20) EPS, FY2026 earnings at ($1.09) EPS, Q1 2027 earnings at ($0.20) EPS, Q3 2027 earnings at ($0.04) EPS, Q4 2027 earnings at ($0.01) EPS and FY2027 earnings at ($0.35) EPS.

Separately, Wall Street Zen downgraded shares of Alpha Cognition from a “hold” rating to a “sell” rating in a report on Saturday, April 4th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat.com, Alpha Cognition currently has an average rating of “Buy” and an average price target of $18.00.

Alpha Cognition Price Performance

Shares of NASDAQ ACOG opened at $6.38 on Friday. Alpha Cognition has a 12-month low of $3.97 and a 12-month high of $11.54. The company has a market capitalization of $138.89 million, a PE ratio of -5.50 and a beta of 2.51. The firm’s 50-day moving average is $5.64 and its two-hundred day moving average is $6.09.

Alpha Cognition (NASDAQ:ACOG) last announced its quarterly earnings results on Thursday, March 26th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.03). Alpha Cognition had a negative net margin of 202.23% and a negative return on equity of 55.71%. The business had revenue of $2.60 million during the quarter, compared to analysts’ expectations of $4.41 million.

Hedge Funds Weigh In On Alpha Cognition

Several institutional investors and hedge funds have recently modified their holdings of ACOG. Geode Capital Management LLC purchased a new position in shares of Alpha Cognition during the second quarter valued at approximately $112,000. Marshall Wace LLP purchased a new position in shares of Alpha Cognition during the second quarter valued at approximately $600,000. Cable Car Capital LP lifted its stake in shares of Alpha Cognition by 68.8% during the second quarter. Cable Car Capital LP now owns 869,002 shares of the company’s stock valued at $8,108,000 after buying an additional 354,278 shares during the period. Massar Capital Management LP purchased a new position in shares of Alpha Cognition during the second quarter valued at approximately $116,000. Finally, Manatuck Hill Partners LLC lifted its stake in shares of Alpha Cognition by 74.6% during the second quarter. Manatuck Hill Partners LLC now owns 117,000 shares of the company’s stock valued at $1,092,000 after buying an additional 50,000 shares during the period.

About Alpha Cognition

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.